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Objective/purpose
Eosinophil infiltration of gut tissue plays a key role in the
pathogenesis of inflammatory bowel diseases (IBD), such
as ulcerative colitis. Using a model of allergic asthma, we
previously demonstrated that eosinophil migration
requires surface expression of the sialomucin CD34, and
that Cd34 deletion dampens asthmatic responses in mice.
Since CD34 is critical for eosinophil migration, we inves-
tigated a role for CD34 in the migration of inflammatory
cells into the colon using a mouse model of IBD.
Methods
To induce ulcerative colitis, we treated animals with 3.5%
dextran sodium sulfate (DSS) and monitored the appear-
ance of clinical symptoms including weight loss, rectal
bleeding and diarrhea. Mice were sacrificed after eight
days of treatment and we measured colon length, enum-
erated hematopoietic lineage subsets infiltrating gut tis-
sue by flow cytometry and prepared colon sections for
histology to determine the severity of gut pathology. In
order to determine the significance of CD34 expression
on hematopoietic cells in the development and progres-
sion of IBD, we reconstituted wild type mice with Cd34-/-
bone marrow to generate chimeras.
Findings
We found that Cd34-/- mice are highly resistant to DSS-
induced IBD with significantly less weight loss and
colon shortening than wildtype controls. Histological
analysis of Cd34-/- colons revealed less crypt loss, less
tissue infiltrate, reduced tissue ulceration and overall
reduced disease severity. We found that approximately
40% of the infiltrating blood cells are eosinophils and
peripheral eosinophil levels are reduced following dis-
ease induction. Intriguingly, eosinophils harvested from
the colon express high levels of CD34 and represent the
majority of CD34+ cells within inflamed gut tissue. Pro-
tection from DSS-induced IBD is largely recapitulated in
mice reconstituted with Cd34-/- bone marrow, demon-
strating the requirement for CD34 expression on hema-
topoietic cells in mucosal inflammation.
Deliverables and relevance
Our findings demonstrate a key role for CD34 on hemato-
poietic cells in the pathology of ulcerative colitis. Gut eosi-
nophils express high levels of CD34 and, similar to our
findings in allergic asthma, we demonstrated that CD34 is
required for optimal eosinophil migration in vivo and
Cd34 deletion results in decreased gut inflammation dur-
ing IBD. Taken together, our findings highlight CD34 as a
potential therapeutic target for IBD treatment and suggest
that therapies targeting CD34 may be sufficient to impair
eosinophil infiltration into the colon.
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